Alkem Laboratories Limited (NSE: ALKEM)
India
· Delayed Price · Currency is INR
5,583.35
-21.40 (-0.38%)
Nov 22, 2024, 3:30 PM IST
Alkem Laboratories Revenue
Alkem Laboratories had revenue of 35.49B INR in the quarter ending September 30, 2024, with 3.17% growth. This brings the company's revenue in the last twelve months to 128.32B, up 3.89% year-over-year. In the fiscal year ending March 31, 2024, Alkem Laboratories had annual revenue of 126.68B with 9.21% growth.
Revenue (ttm)
128.32B
Revenue Growth
+3.89%
P/S Ratio
5.20
Revenue / Employee
7.36M
Employees
17,432
Market Cap
667.57B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 126.68B | 10.68B | 9.21% |
Mar 31, 2023 | 115.99B | 9.65B | 9.08% |
Mar 31, 2022 | 106.34B | 17.69B | 19.96% |
Mar 31, 2021 | 88.65B | 5.21B | 6.24% |
Mar 31, 2020 | 83.44B | 9.87B | 13.42% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAlkem Laboratories News
- 10 days ago - Jefferies maintains underperform on Alkem Labs with target at ₹4,950, indicating 11.1% downside - Business Upturn
- 10 days ago - Nomura on Alkem Labs: Maintains Neutral call, raises target, expects 9.6% upside to Rs 6,097 - Business Upturn
- 10 days ago - Alkem Laboratories Q2 FY25 Results: Revenue up 0.7% YoY to ₹3,414.67, Net Profit up 14.2% YoY - Business Upturn
- 10 days ago - Brigade Enterprises shares dip nearly 4% ahead of Q2 FY25 earnings - Business Upturn
- 18 days ago - Adani Energy shares surge over 5% today – Know why - Business Upturn
- 6 weeks ago - Alkem signs licensing agreement with Sonnet to combat diabetic neuropathy with new drug development - Business Upturn
- 2 months ago - Alkem labs denies its products, Pan-D and Clavam 625, failed quality test - The Times of India
- 2 months ago - Alkem Laboratories denies claims of its Pan-D and Clavam 625 products being not of standard quality - Business Upturn